Merck
CN
  • Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults.

Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults.

Stroke (2015-03-05)
Jae Hoon Moon, Soo Lim, Ji Won Han, Kyoung Min Kim, Sung Hee Choi, Kyong Soo Park, Ki Woong Kim, Hak Chul Jang
摘要

We investigated the association between cardiovascular risk factors, including carotid intima-media thickness (CIMT), and future risk of mild cognitive impairment (MCI) and dementia in elderly subjects. We conducted a population-based prospective study as a part of the Korean Longitudinal Study on Health and Aging. Our study included 348 participants who were nondemented at the baseline (mean age, 71.7±6.3 years) and underwent cognitive evaluation at the 5-year follow-up. Baseline cardiovascular risk factors were compared according to the development of MCI or dementia during the study period. At the baseline evaluation, 278 subjects were cognitively normal and 70 subjects had MCI. Diagnoses of cognitive function either remained unchanged or improved during the study period in 292 subjects (nonprogression group), whereas 56 subjects showed progression of cognitive impairment to MCI or dementia (progression group). The progression group exhibited a higher prevalence of hypertension and greater CIMT compared with the nonprogression group. Other baseline cardiovascular risk factors, including sex, body mass index, diabetes mellitus, insulin resistance, total cholesterol, waist-to-hip ratio, visceral fat, pulse wave velocity, and ankle-brachial index, were not significantly different between 2 groups. The association between greater baseline CIMT and the progression of cognitive impairment was maintained after adjustment for conventional baseline risk factors of cognitive impairment. Greater baseline CIMT was also independently associated with the development of MCI in the subjects whose baseline cognitive function was normal. Greater baseline CIMT was independently associated with the risk of cognitive impairment, such as MCI and dementia in elderly subjects.

材料
货号
品牌
产品描述

Supelco
维生素B12, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
维生素 B 12, ≥98%
Sigma-Aldrich
维生素 B 12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Supelco
腈钴胺(维生素 B12), analytical standard
Sigma-Aldrich
氰钴胺, meets USP testing specifications
氰钴胺, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
氰钴胺, tested according to Ph. Eur.
氰钴胺, British Pharmacopoeia (BP) Assay Standard
Sigma-Aldrich
维生素 B 12, Vetec, reagent grade, ≥98%